The New England Journal of Medicine

This article evaluates the effectiveness of vaccination with Pfizer–BioNTech or Moderna, natural immunity due to previous infection with variants other than omicron, and hybrid immunity (previous infection and vaccination) against symptomatic Omicron infection and against severe, critical, or fatal COVID-19.

Journal Article